Medicine guide
Ogsiveo 150 mg
As listed in the register: Ogsiveo 150 mg, Filmtabletten
150 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Nirogacestatum
- Made by
- Merck (Schweiz) AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Progressive desmoide Tumore
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Merck (Schweiz) AG |
|---|---|
| Active substance | Nirogacestatum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 150 mg |
| Classification | L01XX81 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Ogsiveo 150 mg, Filmtabletten |
| Packs | 56 Tablette(n) |
| Zulassungsnummer | 70389 |
| Dosisstärke | 2 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.